The global latent tuberculosis infection detection market size is expected to reach USD 2.63 billion by 2030. The market is expected to expand at a CAGR of 5.44% from 2024 to 2030. The increased risk of developing active disease from latent tuberculosis infection (LTBI) coupled with the surge in the geriatric population globally is one of the major driving factors for the market growth. In addition, rising awareness about TB detection and various government initiatives for effective diagnosis and screening of tuberculosis infection is another factor contributing to market expansion. For instance, in July 2021, the UKHSA and NHS of England launched a 5-year plan to decrease TB cases in the country. ![Global Latent Tuberculosis Infection Detection Market]( "Global Latent Tuberculosis Infection Detection Market")
The market growth is fueled by the increase in the geriatric population across the globe. For instance, according to the elderly population report of America’s Health Rankings 2021, more than 54 million population aged more than 65 years in the U.S. which accounts for 16.5% of the country’s population. The geriatric population is highly susceptible to developing latent TB infection. Policymakers and public health officials are making improvements in policies to improve the health of older in the country.
Furthermore, ongoing funding activities by leading organizations to promote the diagnosis and testing for tuberculosis are also expected to fuel market growth. For instance, Unitaid is a leading health agency engaged in discovering quick solutions for diseases. In September 2022, the Unitaid launched funding of USD 30 million to boost tuberculosis detection. This funding will support the development of same-day tests and also help in the development of novel diagnostic technologies for tuberculosis.
Similarly, the Global Fund provides support and funding for the management of infectious diseases such as tuberculosis, malaria, and HIV. The organization provides around 76% of global financing for tuberculosis and it has invested around USD 8.5 billion for the management of tuberculosis. Furthermore, in August 2021, the Global Fund provide funds to FIND for the advancement of TB diagnosis and prevention in India. This investment optimized laboratory quality for early diagnosis of TB and improved tuberculosis diagnostic capacity in the country.
In addition, the rising testing efforts globally to promote the diagnosis of TB infection are expected to support market expansion. For instance, in March 2022, QIAGEN N.V. announced that the company has sold 100 million QuantiFERON blood tests since its launch. After this, the company decided to expand QuantiFERON to reach more patients across the globe. Moreover, various strategic initiatives undertaken by leading players to enhance their market share are another factor facilitating market expansion. For instance, in October 2021, QIAGEN announced CE mark approval and roll-out of the QIAreach QuantiFERON-TB test for tuberculosis infection diagnosis.
The market growth is fueled by the increase in the geriatric population across the globe. For instance, according to the elderly population report of America’s Health Rankings 2021, more than 54 million population aged more than 65 years in the U.S. which accounts for 16.5% of the country’s population. The geriatric population is highly susceptible to developing latent TB infection. Policymakers and public health officials are making improvements in policies to improve the health of older in the country.
Furthermore, ongoing funding activities by leading organizations to promote the diagnosis and testing for tuberculosis are also expected to fuel market growth. For instance, Unitaid is a leading health agency engaged in discovering quick solutions for diseases. In September 2022, the Unitaid launched funding of USD 30 million to boost tuberculosis detection. This funding will support the development of same-day tests and also help in the development of novel diagnostic technologies for tuberculosis.
Similarly, the Global Fund provides support and funding for the management of infectious diseases such as tuberculosis, malaria, and HIV. The organization provides around 76% of global financing for tuberculosis and it has invested around USD 8.5 billion for the management of tuberculosis. Furthermore, in August 2021, the Global Fund provide funds to FIND for the advancement of TB diagnosis and prevention in India. This investment optimized laboratory quality for early diagnosis of TB and improved tuberculosis diagnostic capacity in the country.
In addition, the rising testing efforts globally to promote the diagnosis of TB infection are expected to support market expansion. For instance, in March 2022, QIAGEN N.V. announced that the company has sold 100 million QuantiFERON blood tests since its launch. After this, the company decided to expand QuantiFERON to reach more patients across the globe. Moreover, various strategic initiatives undertaken by leading players to enhance their market share are another factor facilitating market expansion. For instance, in October 2021, QIAGEN announced CE mark approval and roll-out of the QIAreach QuantiFERON-TB test for tuberculosis infection diagnosis.
Latent Tuberculosis Infection Detection Market Report Highlights
- In test type, the IGRA segment is expected to grow at the fastest rate over the forecast period owing to increasing recommendations for IGRAs from various public health authorities
- Based on application segment, the PLHIV accounted for the largest revenue share in 2023 due to the rising risk of developing TB in people suffering from HIV infection
- The diagnostic laboratories segment was the highest revenue contributor in 2023. Whereas the academic and research institutions segment is expected to exhibit the fastest CAGR during the projected period
- Asia Pacific is expected to exhibit the fastest growth over the forecast period due to the rising investments by market players and increasing research activities in the region
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Brand
1.2.2. Test Type
1.2.3. Application
1.2.4. End-use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.2. Segment Definitions
1.2.1. Brand
1.2.2. Test Type
1.2.3. Application
1.2.4. End-use
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Brand and test type outlook
2.2.2. Application and end-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Brand and test type outlook
2.2.2. Application and end-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Latent Tuberculosis Infection Detection Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing risk of developing active tuberculosis infection from LTBI
3.2.1.2. Increasing funding programs to promote TB diagnosis
3.2.1.3. Favorable government initiatives for combating TB
3.2.1.4. Surge in geriatric population
3.2.2. Market restraint analysis
3.2.2.1. Presence of stringent rules and regulations pertaining to diagnosis
3.2.3. Market opportunity analysis
3.2.4. Unmet need analysis
3.3. Latent Tuberculosis Infection Detection Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environment landscape
3.3.3. Pricing Analysis
3.3.4. Volume Analysis
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing risk of developing active tuberculosis infection from LTBI
3.2.1.2. Increasing funding programs to promote TB diagnosis
3.2.1.3. Favorable government initiatives for combating TB
3.2.1.4. Surge in geriatric population
3.2.2. Market restraint analysis
3.2.2.1. Presence of stringent rules and regulations pertaining to diagnosis
3.2.3. Market opportunity analysis
3.2.4. Unmet need analysis
3.3. Latent Tuberculosis Infection Detection Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environment landscape
3.3.3. Pricing Analysis
3.3.4. Volume Analysis
Chapter 4. Latent Tuberculosis Infection Detection Market: Brand Estimates & Trend Analysis
4.1. Global Latent Tuberculosis Infection Detection Market: Brand Dashboard
4.2. Global Latent Tuberculosis Infection Detection Market: Brand Movement Analysis
4.3. Global Latent Tuberculosis Infection Detection Market by brand, Revenue
4.4. QFT-Plus (QuantiFERON-TB Gold Plus)
4.4.1. QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Others
4.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
4.2. Global Latent Tuberculosis Infection Detection Market: Brand Movement Analysis
4.3. Global Latent Tuberculosis Infection Detection Market by brand, Revenue
4.4. QFT-Plus (QuantiFERON-TB Gold Plus)
4.4.1. QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Others
4.5.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Latent Tuberculosis Infection Detection Market: Test Type Estimates & Trend Analysis
5.1. Global Latent Tuberculosis Infection Detection Market: Test Type Dashboard
5.2. Global Latent Tuberculosis Infection Detection Market: Test Type Movement Analysis
5.3. Global Latent Tuberculosis Infection Detection Market by Test Type, Revenue
5.4. Tuberculin Skin Test (TST)
5.4.1. Tuberculin Skin Test (TST) market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Interferon Gamma Released Assay (IGRA)
5.5.1. Interferon Gamma Released Assay (IGRA) market estimates and forecasts 2018 to 2030 (USD Million)
5.2. Global Latent Tuberculosis Infection Detection Market: Test Type Movement Analysis
5.3. Global Latent Tuberculosis Infection Detection Market by Test Type, Revenue
5.4. Tuberculin Skin Test (TST)
5.4.1. Tuberculin Skin Test (TST) market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Interferon Gamma Released Assay (IGRA)
5.5.1. Interferon Gamma Released Assay (IGRA) market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Latent Tuberculosis Infection Detection Market: Application Estimates & Trend Analysis
6.1. Global Latent Tuberculosis Infection Detection Market: Application Dashboard
6.2. Global Latent Tuberculosis Infection Detection Market: Application Movement Analysis
6.3. Global Latent Tuberculosis Infection Detection Market by Application, Revenue
6.4. Household Contacts with Pulmonary TB
6.4.1. Household contacts with pulmonary TB market estimates and forecasts 2018 to 2030 (USD Million)
6.5. PLHIV
6.5.1. PLHIV market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
6.2. Global Latent Tuberculosis Infection Detection Market: Application Movement Analysis
6.3. Global Latent Tuberculosis Infection Detection Market by Application, Revenue
6.4. Household Contacts with Pulmonary TB
6.4.1. Household contacts with pulmonary TB market estimates and forecasts 2018 to 2030 (USD Million)
6.5. PLHIV
6.5.1. PLHIV market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Latent Tuberculosis Infection Detection Market: End-use Estimates & Trend Analysis
7.1. Global Latent Tuberculosis Infection Detection Market: End-use Dashboard
7.2. Global Latent Tuberculosis Infection Detection Market: End-use Movement Analysis
7.3. Global Latent Tuberculosis Infection Detection Market by End-use, Revenue
7.4. Diagnostic Laboratories
7.4.1. Diagnostic laboratories market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Hospitals/Clinics
7.5.1. Hospitals/Clinics market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Academic & Research Institutions
7.6.1. Academic & research institutions market estimates and forecasts 2018 to 2030 (USD Million)
7.2. Global Latent Tuberculosis Infection Detection Market: End-use Movement Analysis
7.3. Global Latent Tuberculosis Infection Detection Market by End-use, Revenue
7.4. Diagnostic Laboratories
7.4.1. Diagnostic laboratories market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Hospitals/Clinics
7.5.1. Hospitals/Clinics market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Academic & Research Institutions
7.6.1. Academic & research institutions market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Latent Tuberculosis Infection Detection Market: Regional Estimates & Trend Analysis by Product Type, Technology, and End-use
8.1. Regional Dashboard
8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.3. North America
8.3.1. U.S.
8.3.1.1. Key country dynamics
8.3.1.2. Regulatory framework/ reimbursement structure
8.3.1.3. Competitive scenario
8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.3.2. Canada
8.3.2.1. Key country dynamics
8.3.2.2. Regulatory framework/ reimbursement structure
8.3.2.3. Competitive scenario
8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4. Europe
8.4.1. UK
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.2. Germany
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.3. France
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.4. Italy
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.5. Spain
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.6. Norway
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Regulatory framework/ reimbursement structure
8.4.7.3. Competitive scenario
8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.8. Denmark
8.4.8.1. Key country dynamics
8.4.8.2. Regulatory framework/ reimbursement structure
8.4.8.3. Competitive scenario
8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.9. Netherlands
8.4.9.1. Key country dynamics
8.4.9.2. Regulatory framework/ reimbursement structure
8.4.9.3. Competitive scenario
8.4.9.4. Netherlands market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.10. Belgium
8.4.10.1. Key country dynamics
8.4.10.2. Regulatory framework/ reimbursement structure
8.4.10.3. Competitive scenario
8.4.10.4. Belgium market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.11. Finland
8.4.11.1. Key country dynamics
8.4.11.2. Regulatory framework/ reimbursement structure
8.4.11.3. Competitive scenario
8.4.11.4. Finland market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.12. Luxembourg
8.4.12.1. Key country dynamics
8.4.12.2. Regulatory framework/ reimbursement structure
8.4.12.3. Competitive scenario
8.4.12.4. Luxembourg market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.13. Iceland
8.4.13.1. Key country dynamics
8.4.13.2. Regulatory framework/ reimbursement structure
8.4.13.3. Competitive scenario
8.4.13.4. Iceland market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.3. India
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.4. Australia
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.6. Thailand
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.7. Singapore
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework/ reimbursement structure
8.5.7.3. Competitive scenario
8.5.7.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.8. Bangladesh
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework/ reimbursement structure
8.5.8.3. Competitive scenario
8.5.8.4. Bangladesh market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.6.2. Mexico
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.6.3. Argentina
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.7.2. Saudi Arabia
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.7.3. UAE
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.7.4. Kuwait
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.3. North America
8.3.1. U.S.
8.3.1.1. Key country dynamics
8.3.1.2. Regulatory framework/ reimbursement structure
8.3.1.3. Competitive scenario
8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.3.2. Canada
8.3.2.1. Key country dynamics
8.3.2.2. Regulatory framework/ reimbursement structure
8.3.2.3. Competitive scenario
8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4. Europe
8.4.1. UK
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.2. Germany
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.3. France
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.4. Italy
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.5. Spain
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.6. Norway
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Regulatory framework/ reimbursement structure
8.4.7.3. Competitive scenario
8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.8. Denmark
8.4.8.1. Key country dynamics
8.4.8.2. Regulatory framework/ reimbursement structure
8.4.8.3. Competitive scenario
8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.9. Netherlands
8.4.9.1. Key country dynamics
8.4.9.2. Regulatory framework/ reimbursement structure
8.4.9.3. Competitive scenario
8.4.9.4. Netherlands market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.10. Belgium
8.4.10.1. Key country dynamics
8.4.10.2. Regulatory framework/ reimbursement structure
8.4.10.3. Competitive scenario
8.4.10.4. Belgium market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.11. Finland
8.4.11.1. Key country dynamics
8.4.11.2. Regulatory framework/ reimbursement structure
8.4.11.3. Competitive scenario
8.4.11.4. Finland market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.12. Luxembourg
8.4.12.1. Key country dynamics
8.4.12.2. Regulatory framework/ reimbursement structure
8.4.12.3. Competitive scenario
8.4.12.4. Luxembourg market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.4.13. Iceland
8.4.13.1. Key country dynamics
8.4.13.2. Regulatory framework/ reimbursement structure
8.4.13.3. Competitive scenario
8.4.13.4. Iceland market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.3. India
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.4. Australia
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.6. Thailand
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.7. Singapore
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework/ reimbursement structure
8.5.7.3. Competitive scenario
8.5.7.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.5.8. Bangladesh
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework/ reimbursement structure
8.5.8.3. Competitive scenario
8.5.8.4. Bangladesh market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.6.2. Mexico
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.6.3. Argentina
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.7.2. Saudi Arabia
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.7.3. UAE
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
8.7.4. Kuwait
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) (Number of tests in thousands)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. QIAGEN
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. BIOMÉRIEUX
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Oxford Immunotec
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. SD Biosensor, INC.
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Wantai BioPharm
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Lionex GmbH
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Sanofi
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Serum Institute of India Pvt. Ltd
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. ARKRAY, Inc.
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Par Pharmaceutical, Inc.
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Product benchmarking
9.3.13.4. Strategic initiatives
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. QIAGEN
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. BIOMÉRIEUX
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Oxford Immunotec
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. SD Biosensor, INC.
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Wantai BioPharm
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Lionex GmbH
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Sanofi
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Serum Institute of India Pvt. Ltd
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. ARKRAY, Inc.
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Par Pharmaceutical, Inc.
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Product benchmarking
9.3.13.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America latent tuberculosis infection detection market, by region, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 3 North America latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 4 North America latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 5 North America latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 6 North America latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 7 U.S. latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 8 U.S. latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 9 U.S. latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 10 U.S. latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 11 Canada latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 12 Canada latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 13 Canada latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 14 Canada latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 15 Europe latent tuberculosis infection detection market, by region, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 16 Europe latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 17 Europe latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 18 Europe latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 19 Europe latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 20 Germany latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 21 Germany latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 22 Germany latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 23 Germany latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 24 UK latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 25 UK latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 26 UK latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 27 UK latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 28 France latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 29 France latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 30 France latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 31 France latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 32 Italy latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 33 Italy latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 34 Italy latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 35 Italy latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 36 Spain latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 37 Spain latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 38 Spain latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 39 Spain latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 40 Denmark latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 41 Denmark latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 42 Denmark latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 43 Denmark latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 44 Sweden latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 45 Sweden latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 46 Sweden latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 47 Sweden latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 48 Norway latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 49 Norway latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 50 Norway latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 51 Norway latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 52 Netherlands latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 53 Netherlands latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 54 Netherlands latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 55 Netherlands latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 56 Belgium latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 57 Belgium latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 58 Belgium latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 59 Belgium latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 60 Finland latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 61 Finland latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 62 Finland latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 63 Finland latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 64 Luxembourg latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 65 Luxembourg latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 66 Luxembourg latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 67 Luxembourg latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 68 Iceland latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 69 Iceland latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 70 Iceland latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 71 Iceland latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 72 Asia Pacific latent tuberculosis infection detection market, by region, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 73 Asia Pacific latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 74 Asia Pacific latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 75 Asia Pacific latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 76 Aisa Pacific latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 77 China latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 78 China latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 79 China latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 80 China latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 81 Japan latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 82 Japan latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 83 Japan latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 84 Japan latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 85 India latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 86 India latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 87 India latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 88 India latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 89 South Korea latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 90 South Korea latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 91 South Korea latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 92 South Korea latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 93 Australia latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 94 Australia latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 95 Australia latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 96 Australia latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 97 Thailand latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 98 Thailand latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 99 Thailand latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 100 Thailand latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 101 Singapore latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 102 Singapore latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 103 Singapore latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 104 Singapore latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 105 Bangladesh latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 106 Bangladesh latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 107 Bangladesh latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 108 Bangladesh latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 109 Latin America latent tuberculosis infection detection market, by region, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 110 Latin America latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 111 Latin America latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 112 Latin America latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 113 Latin America latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 114 Brazil latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 115 Brazil latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 116 Brazil latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 117 Brazil latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 118 Mexico latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 119 Mexico latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 120 Mexico latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 121 Mexico latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 122 Argentina latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 123 Argentina latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 124 Argentina latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 125 Argentina latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 126 MEA latent tuberculosis infection detection market, by region, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 127 MEA latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 128 MEA latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 129 MEA latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 130 MEA latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 131 South Africa latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 132 South Africa latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 133 South Africa latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 134 South Africa latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 135 Saudi Arabia latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 136 Saudi Arabia latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 137 Saudi Arabia latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 138 Saudi Arabia latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 139 UAE latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 140 UAE latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 141 UAE latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 142 UAE latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 143 Kuwait latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 144 Kuwait latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 145 Kuwait latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 146 Kuwait latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 2 North America latent tuberculosis infection detection market, by region, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 3 North America latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 4 North America latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 5 North America latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 6 North America latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 7 U.S. latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 8 U.S. latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 9 U.S. latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 10 U.S. latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 11 Canada latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 12 Canada latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 13 Canada latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 14 Canada latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 15 Europe latent tuberculosis infection detection market, by region, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 16 Europe latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 17 Europe latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 18 Europe latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 19 Europe latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 20 Germany latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 21 Germany latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 22 Germany latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 23 Germany latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 24 UK latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 25 UK latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 26 UK latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 27 UK latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 28 France latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 29 France latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 30 France latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 31 France latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 32 Italy latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 33 Italy latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 34 Italy latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 35 Italy latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 36 Spain latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 37 Spain latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 38 Spain latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 39 Spain latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 40 Denmark latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 41 Denmark latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 42 Denmark latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 43 Denmark latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 44 Sweden latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 45 Sweden latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 46 Sweden latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 47 Sweden latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 48 Norway latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 49 Norway latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 50 Norway latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 51 Norway latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 52 Netherlands latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 53 Netherlands latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 54 Netherlands latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 55 Netherlands latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 56 Belgium latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 57 Belgium latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 58 Belgium latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 59 Belgium latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 60 Finland latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 61 Finland latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 62 Finland latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 63 Finland latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 64 Luxembourg latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 65 Luxembourg latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 66 Luxembourg latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 67 Luxembourg latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 68 Iceland latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 69 Iceland latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 70 Iceland latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 71 Iceland latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 72 Asia Pacific latent tuberculosis infection detection market, by region, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 73 Asia Pacific latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 74 Asia Pacific latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 75 Asia Pacific latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 76 Aisa Pacific latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 77 China latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 78 China latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 79 China latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 80 China latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 81 Japan latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 82 Japan latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 83 Japan latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 84 Japan latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 85 India latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 86 India latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 87 India latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 88 India latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 89 South Korea latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 90 South Korea latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 91 South Korea latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 92 South Korea latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 93 Australia latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 94 Australia latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 95 Australia latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 96 Australia latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 97 Thailand latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 98 Thailand latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 99 Thailand latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 100 Thailand latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 101 Singapore latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 102 Singapore latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 103 Singapore latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 104 Singapore latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 105 Bangladesh latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 106 Bangladesh latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 107 Bangladesh latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 108 Bangladesh latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 109 Latin America latent tuberculosis infection detection market, by region, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 110 Latin America latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 111 Latin America latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 112 Latin America latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 113 Latin America latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 114 Brazil latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 115 Brazil latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 116 Brazil latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 117 Brazil latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 118 Mexico latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 119 Mexico latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 120 Mexico latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 121 Mexico latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 122 Argentina latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 123 Argentina latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 124 Argentina latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 125 Argentina latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 126 MEA latent tuberculosis infection detection market, by region, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 127 MEA latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 128 MEA latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 129 MEA latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 130 MEA latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 131 South Africa latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 132 South Africa latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 133 South Africa latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 134 South Africa latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 135 Saudi Arabia latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 136 Saudi Arabia latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 137 Saudi Arabia latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 138 Saudi Arabia latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 139 UAE latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 140 UAE latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 141 UAE latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 142 UAE latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 143 Kuwait latent tuberculosis infection detection market, by brand, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 144 Kuwait latent tuberculosis infection detection market, by test type, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 145 Kuwait latent tuberculosis infection detection market, by application, 2018-2030 (USD Million) (Number of Tests in Thousands)
Table 146 Kuwait latent tuberculosis infection detection market, by end-use, 2018-2030 (USD Million) (Number of Tests in Thousands)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Latent tuberculosis infection detection market: market outlook
Figure 14 Latent tuberculosis infection detection competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Latent tuberculosis infection detection market driver impact
Figure 18 Latent tuberculosis infection detection market restraint impact
Figure 19 Latent tuberculosis infection detection market: Brand movement analysis
Figure 20 Latent tuberculosis infection detection market: Brand outlook and key takeaways
Figure 21 QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 22 Others estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 23 Latent tuberculosis infection detection market: Test type movement analysis
Figure 24 Latent tuberculosis infection detection market: Test type outlook and key takeaways
Figure 25 Tuberculin Skin Test (TST) market estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 26 Interferon Gamma Released Assay (IGRA) estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 27 Latent tuberculosis infection detection market: Application movement analysis
Figure 28 Latent tuberculosis infection detection market: Application outlook and key takeaways
Figure 29 Household contacts with pulmonary TB market estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 30 PLHIV estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 31 Others estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 32 Latent tuberculosis infection detection market: End-use movement analysis
Figure 33 Latent tuberculosis infection detection market: End-use outlook and key takeaways
Figure 34 Diagnostics laboratories estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 35 Hospital/Clinics market estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 36 Academic & research institutions market estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 37 Global latent tuberculosis infection detection market: Regional movement analysis
Figure 38 Global latent tuberculosis infection detection market: Regional outlook and key takeaways
Figure 39 Global latent tuberculosis infection detection market share and leading players
Figure 40 North America, by country
Figure 41 North America market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 42 U.S. key country dynamics
Figure 43 U.S. market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 44 Canada key country dynamics
Figure 45 Canada market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 46 Europe market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 47 UK key country dynamics
Figure 48 UK market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 49 Germany key country dynamics
Figure 50 Germany market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 51 France key country dynamics
Figure 52 France market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 53 Italy key country dynamics
Figure 54 Italy market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 55 Spain key country dynamics
Figure 56 Spain market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 57 Denmark key country dynamics
Figure 58 Denmark market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 59 Sweden key country dynamics
Figure 60 Sweden market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 61 Norway key country dynamics
Figure 62 Norway market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 63 Netherlands key country dynamics
Figure 64 Netherlands market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 65 Belgium key country dynamics
Figure 66 Belgium market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 67 Finland key country dynamics
Figure 68 Finland market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 69 Luxembourg key country dynamics
Figure 70 Luxembourg market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 71 Iceland key country dynamics
Figure 72 Iceland market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 73 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 74 China key country dynamics
Figure 75 China market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 76 Japan key country dynamics
Figure 77 Japan market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 78 India key country dynamics
Figure 79 India market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 80 Thailand key country dynamics
Figure 81 Thailand market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 82 South Korea key country dynamics
Figure 83 South Korea market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 84 Australia key country dynamics
Figure 85 Australia market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 86 Singapore key country dynamics
Figure 87 Singapore market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 88 Bangladesh key country dynamics
Figure 89 Bangladesh market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 90 Latin America market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 91 Brazil key country dynamics
Figure 92 Brazil market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 93 Mexico key country dynamics
Figure 94 Mexico market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 95 Argentina key country dynamics
Figure 96 Argentina market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 97 Middle East and Africa market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 98 South Africa key country dynamics
Figure 99 South Africa market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 100 Saudi Arabia key country dynamics
Figure 101 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 102 UAE key country dynamics
Figure 103 UAE market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 104 Kuwait key country dynamics
Figure 105 Kuwait market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 106 Market share of key market players - Latent tuberculosis infection detection market
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews in North America
Figure 5 Primary interviews in Europe
Figure 6 Primary interviews in APAC
Figure 7 Primary interviews in Latin America
Figure 8 Primary interviews in MEA
Figure 9 Market research approaches
Figure 10 Value-chain-based sizing & forecasting
Figure 11 QFD modeling for market share assessment
Figure 12 Market formulation & validation
Figure 13 Latent tuberculosis infection detection market: market outlook
Figure 14 Latent tuberculosis infection detection competitive insights
Figure 15 Parent market outlook
Figure 16 Related/ancillary market outlook
Figure 17 Latent tuberculosis infection detection market driver impact
Figure 18 Latent tuberculosis infection detection market restraint impact
Figure 19 Latent tuberculosis infection detection market: Brand movement analysis
Figure 20 Latent tuberculosis infection detection market: Brand outlook and key takeaways
Figure 21 QFT-Plus (QuantiFERON-TB Gold Plus) market estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 22 Others estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 23 Latent tuberculosis infection detection market: Test type movement analysis
Figure 24 Latent tuberculosis infection detection market: Test type outlook and key takeaways
Figure 25 Tuberculin Skin Test (TST) market estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 26 Interferon Gamma Released Assay (IGRA) estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 27 Latent tuberculosis infection detection market: Application movement analysis
Figure 28 Latent tuberculosis infection detection market: Application outlook and key takeaways
Figure 29 Household contacts with pulmonary TB market estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 30 PLHIV estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 31 Others estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 32 Latent tuberculosis infection detection market: End-use movement analysis
Figure 33 Latent tuberculosis infection detection market: End-use outlook and key takeaways
Figure 34 Diagnostics laboratories estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 35 Hospital/Clinics market estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 36 Academic & research institutions market estimates and forecast, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 37 Global latent tuberculosis infection detection market: Regional movement analysis
Figure 38 Global latent tuberculosis infection detection market: Regional outlook and key takeaways
Figure 39 Global latent tuberculosis infection detection market share and leading players
Figure 40 North America, by country
Figure 41 North America market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 42 U.S. key country dynamics
Figure 43 U.S. market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 44 Canada key country dynamics
Figure 45 Canada market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 46 Europe market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 47 UK key country dynamics
Figure 48 UK market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 49 Germany key country dynamics
Figure 50 Germany market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 51 France key country dynamics
Figure 52 France market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 53 Italy key country dynamics
Figure 54 Italy market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 55 Spain key country dynamics
Figure 56 Spain market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 57 Denmark key country dynamics
Figure 58 Denmark market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 59 Sweden key country dynamics
Figure 60 Sweden market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 61 Norway key country dynamics
Figure 62 Norway market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 63 Netherlands key country dynamics
Figure 64 Netherlands market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 65 Belgium key country dynamics
Figure 66 Belgium market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 67 Finland key country dynamics
Figure 68 Finland market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 69 Luxembourg key country dynamics
Figure 70 Luxembourg market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 71 Iceland key country dynamics
Figure 72 Iceland market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 73 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 74 China key country dynamics
Figure 75 China market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 76 Japan key country dynamics
Figure 77 Japan market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 78 India key country dynamics
Figure 79 India market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 80 Thailand key country dynamics
Figure 81 Thailand market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 82 South Korea key country dynamics
Figure 83 South Korea market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 84 Australia key country dynamics
Figure 85 Australia market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 86 Singapore key country dynamics
Figure 87 Singapore market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 88 Bangladesh key country dynamics
Figure 89 Bangladesh market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 90 Latin America market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 91 Brazil key country dynamics
Figure 92 Brazil market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 93 Mexico key country dynamics
Figure 94 Mexico market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 95 Argentina key country dynamics
Figure 96 Argentina market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 97 Middle East and Africa market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 98 South Africa key country dynamics
Figure 99 South Africa market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 100 Saudi Arabia key country dynamics
Figure 101 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 102 UAE key country dynamics
Figure 103 UAE market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 104 Kuwait key country dynamics
Figure 105 Kuwait market estimates and forecasts, 2018-2030 (USD Million) (Number of tests in thousands)
Figure 106 Market share of key market players - Latent tuberculosis infection detection market
Companies Mentioned
- QIAGEN
- BIOMÉRIEUX
- Oxford Immunotec
- SD Biosensor, INC.
- Wantai BioPharm
- Lionex GmbH
- Sanofi
- Serum Institute of India Pvt. Ltd
- ARKRAY, Inc.
- Par Pharmaceutical, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 125 |
| Published | June 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 1.75 Billion |
| Forecasted Market Value ( USD | $ 2.63 Billion |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
